DEVELOPMENT AND VALIDATION OF NEW LC-MS/MS METHOD FOR DETERMINATION OF UNBOUND TACROLIMUS IN PLASMA IN CYP 3A5 EXPRESSORS AND NON-EXPRESSORS
2019/33/N/NZ7/01631
Keywords
Descriptors
- NZ7_014: Farmacja, farmakoterapia, farmakologia
- NZ5_007: Leczenie chorób człowieka
- NZ2_002: Genomika, transkryptomika i epigenomika
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Warszawski Uniwersytet Medyczny
Voivodeship: mazowieckie
Principal investigator (from the host institution)
Number of co-investigators in the project: 3
Call
PRELUDIUM 17 – announced on 2019-03-15
- Amount awarded
- 210 000 PLN
- Project start date
- 2020-03-09
- Project end date
- 2023-03-08
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Development and Validation of the New Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Unbound Tacrolimus in the Plasma Ultrafiltrate of Transplant Recipients
- Authors:
- Magdalena Bodnar-Broniarczyk, Karola Warzyszyńska, Katarzyna Czerwińska, Dorota Marszałek, Natalia Dziewa, Maciej Kosieradzki, Tomasz Pawiński
- Academic press:
- Pharmaceutics (year: 2022, volume: 14, pages: 632), Publisher: MDPI
- Status:
- Published
- DOI:
- 10.3390/pharmaceutics14030632 – link to the publication